Literature DB >> 9190918

Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice.

Y Nakamoto1, L G Guidotti, V Pasquetto, R D Schreiber, F V Chisari.   

Abstract

The current study was designed to explore the relative contribution of Fas ligand (FasL), perforin, IFN-gamma, and TNF-alpha-induced death pathways in the pathogenesis of CTL-induced liver disease. Hepatitis B virus-specific CTL that are genetically unable to produce either FasL, perforin, or IFN-gamma were injected into Fas-competent and Fas-deficient hepatitis B virus transgenic mice that are either sensitive or resistant to the cytopathic effects of IFN-gamma based on the extent to which their hepatocytes retain hepatitis B surface Ag (HBsAg). The results of these experiments indicate that FasL- and perforin-dependent signals are primarily responsible for the induction of liver disease in the absence of HBsAg retention, but both signaling pathways must be activated simultaneously by the CTL in order to kill the hepatocyte in vivo. In contrast, neither FasL nor perforin are required to kill hepatocytes that retain HBsAg as long as the CTL secrete IFN-gamma on antigen recognition. Finally the results indicate that, irrespective of their HBsAg content, hepatocytes are much less sensitive to destruction by TNF-alpha than by the other death pathways. While all of these death pathways appear to be operative during a normal CTL response, the current experiments suggest that the target cell determines which pathway is dominant and selects its mode of execution.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9190918

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Apoptosis-related proteins, BCL-2, BAX, FAS, FAS-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infection.

Authors:  J Ehrmann; D Galuszková; J Ehrmann; I Krc; V Jezdinská; B Vojtések; P G Murray; Z Koláo
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection.

Authors:  Marwan S Abougergi; Sarah J Gidner; David K Spady; Bonnie C Miller; Dwain L Thiele
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

3.  Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Authors:  Gregor Ebert; Simon Preston; Cody Allison; James Cooney; Jesse G Toe; Michael D Stutz; Samar Ojaimi; Hamish W Scott; Nikola Baschuk; Ueli Nachbur; Joseph Torresi; Ruth Chin; Danielle Colledge; Xin Li; Nadia Warner; Peter Revill; Scott Bowden; John Silke; C Glenn Begley; Marc Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

4.  Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection.

Authors:  C M Lin; R J Plenter; M Coulombe; R G Gill
Journal:  Am J Transplant       Date:  2016-07-07       Impact factor: 8.086

Review 5.  The effect of IFNgamma on the hepatocyte: cell cycle and apoptosis.

Authors:  B J Tura; K E Bunyan; D J Harrison
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

6.  Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis.

Authors:  P D Hodgson; M D Grant; T I Michalak
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

7.  In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model.

Authors:  T Cao; P Meuleman; I Desombere; M Sällberg; G Leroux-Roels
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

8.  Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes.

Authors:  E R Jensen; A A Glass; W R Clark; E J Wing; J F Miller; S H Gregory
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Immune effectors required for hepatitis B virus clearance.

Authors:  Priscilla L Yang; Alana Althage; Josan Chung; Holly Maier; Stefan Wieland; Masanori Isogawa; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes.

Authors:  Senji Kasahara; Kazuki Ando; Kuniaki Saito; Kenji Sekikawa; Hiroyasu Ito; Tetsuya Ishikawa; Hiroo Ohnishi; Mitsuru Seishima; Shinichi Kakumu; Hisataka Moriwaki
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.